Signaling pathways activated and regulated by stem cell-derived exosome therapy

Ding Li; Danni Li; Jiaojiao Li; Khawar Ali Shahzad; Yanhong Wang; Fei Tan

doi:10.1186/s13578-024-01277-7

journal article Open Access Aug 20, 2024

Signaling pathways activated and regulated by stem cell-derived exosome therapy

Ding Li

Danni Li

Jiaojiao Li

Khawar Ali Shahzad Yanhong Wang

Fei Tan

Cell & Bioscience Vol. 14 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s13578-024-01277-7

Abstract

AbstractStem cell-derived exosomes exert comparable therapeutic effects to those of their parental stem cells without causing immunogenic, tumorigenic, and ethical disadvantages. Their therapeutic advantages are manifested in the management of a broad spectrum of diseases, and their dosing versatility are exemplified by systemic administration and local delivery. Furthermore, the activation and regulation of various signaling cascades have provided foundation for the claimed curative effects of exosomal therapy. Unlike other relevant reviews focusing on the upstream aspects (e.g., yield, isolation, modification), and downstream aspects (e.g. phenotypic changes, tissue response, cellular behavior) of stem cell-derived exosome therapy, this unique review endeavors to focus on various affected signaling pathways. After meticulous dissection of relevant literature from the past five years, we present this comprehensive, up-to-date, disease-specific, and pathway-oriented review. Exosomes sourced from various types of stem cells can regulate major signaling pathways (e.g., the PTEN/PI3K/Akt/mTOR, NF-κB, TGF-β, HIF-1α, Wnt, MAPK, JAK-STAT, Hippo, and Notch signaling cascades) and minor pathways during the treatment of numerous diseases encountered in orthopedic surgery, neurosurgery, cardiothoracic surgery, plastic surgery, general surgery, and other specialties. We provide a novel perspective in future exosome research through bridging the gap between signaling pathways and surgical indications when designing further preclinical studies and clinical trials.

Topics

No keywords indexed for this article. Browse by subject →

References

182

[1]

Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7. https://doi.org/10.1038/s41392-022-01134-4. 10.1038/s41392-022-01134-4

[2]

Stem cells: past, present, and future

Wojciech Zakrzewski, Maciej Dobrzyński, Maria Szymonowicz et al.

Stem Cell Research & Therapy 2019 10.1186/s13287-019-1165-5

[3]

Stem cell-derived exosome versus stem cell therapy

Kaiyue Zhang, Ke Cheng

Nature Reviews Bioengineering 2023 10.1038/s44222-023-00064-2

[4]

Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in Regenerative Medicine. Int J Mol Sci. 2017;18. https://doi.org/10.3390/ijms18091852. 10.3390/ijms18091852

[5]

Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P, Exosome. A review of its classification, isolation techniques, Storage, Diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917–34. https://doi.org/10.2147/IJN.S264498. 10.2147/ijn.s264498

[6]

Ren K. Exosomes in perspective: a potential surrogate for stem cell therapy. Odontology. 2019;107:271–84. https://doi.org/10.1007/s10266-018-0395-9. 10.1007/s10266-018-0395-9

[7]

Hastuti S, Idroes R, Imran I, Ramli Y, Abas AH, Tallei TE. hUMSC vs. hUMSC-Exosome: which one is better for Epilepsy? Pharmaceuticals (Basel). 2022;15. https://doi.org/10.3390/ph15101247. 10.3390/ph15101247

[8]

Doyle LM, Wang MZ. Overview of Extracellular vesicles, their origin, composition, purpose, and methods for Exosome isolation and analysis. Cells. 2019;8. https://doi.org/10.3390/cells8070727. 10.3390/cells8070727

[9]

Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19. https://doi.org/10.1186/s12964-021-00730-1. 10.1186/s12964-021-00730-1

[10]

Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. https://doi.org/10.1186/s13578-019-0282-2. 10.1186/s13578-019-0282-2

[11]

Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022;20:145. https://doi.org/10.1186/s12964-022-00959-4. 10.1186/s12964-022-00959-4

[12]

Zhou B, Xu K, Zheng X, Chen T, Wang J, Song Y, Shao Y, Zheng S. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther. 2020;5:144. https://doi.org/10.1038/s41392-020-00258-9. 10.1038/s41392-020-00258-9

[13]

Exosomes in bodily fluids are a highly stable resource of disease biomarkers

Stephanie Boukouris, Suresh Mathivanan

PROTEOMICS – Clinical Applications 2015 10.1002/prca.201400114

[14]

Li M, Li S, Du C, Zhang Y, Li Y, Chu L, Han X, Galons H, Zhang Y, Sun H, Yu P. Exosomes from different cells: characteristics, modifications, and therapeutic applications. Eur J Med Chem. 2020;207:112784. https://doi.org/10.1016/j.ejmech.2020.112784. 10.1016/j.ejmech.2020.112784

[15]

Pitt JM, Andre F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. J Clin Investig. 2016;126:1224–32. https://doi.org/10.1172/JCI81137. 10.1172/jci81137

[16]

Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C, Daugaard M, Guns E, Hoorfar M, Li ITS. Challenges and opportunities in exosome research-perspectives from biology, engineering, and cancer therapy. APL Bioeng. 2019;3:011503. https://doi.org/10.1063/1.5087122. 10.1063/1.5087122

[17]

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

Yanhua Tian, Suping Li, Jian Song et al.

Biomaterials 2014 10.1016/j.biomaterials.2013.11.083

[18]

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism

Ling-Yu Tian, Daniel J. Smit, Manfred Jücker

International Journal of Molecular Sciences 10.3390/ijms24032652

[19]

Prvanovic M, Nedeljkovic M, Tanic N, Tomic T, Terzic T, Milovanovic Z, Maksimovic Z, Tanic N. Role of PTEN, PI3K, and mTOR in Triple-negative breast Cancer. Life (Basel). 2021;11. https://doi.org/10.3390/life11111247. 10.3390/life11111247

[20]

Lim HJ, Crowe P, Yang JL. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J Cancer Res Clin Oncol. 2015;141:671–89. https://doi.org/10.1007/s00432-014-1803-3. 10.1007/s00432-014-1803-3

[21]

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam et al.

Molecular Cancer 10.1186/s12943-023-01827-6

[22]

Dienstmann R, Rodon J, Serra V, Tabernero J. Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors. Mol Cancer Ther. 2014;13:1021–31. https://doi.org/10.1158/1535-7163.MCT-13-0639. 10.1158/1535-7163.mct-13-0639

[23]

Lee YR, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19:547–62. https://doi.org/10.1038/s41580-018-0015-0. 10.1038/s41580-018-0015-0

[24]

Targeting PI3K/Akt signal transduction for cancer therapy

Yan He, Miao Miao Sun, Guo Geng Zhang et al.

Signal Transduction and Targeted Therapy 2021 10.1038/s41392-021-00828-5

[25]

AKT/PKB Signaling: Navigating the Network

Brendan D. Manning, Alex Toker

Cell 2017 10.1016/j.cell.2017.04.001

[26]

Nitulescu GM, Van De Venter M, Nitulescu G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Gradinaru D, Tsatsakis A, Tsoukalas D, et al. The akt pathway in oncology therapy and beyond (review). Int J Oncol. 2018;53:2319–31. https://doi.org/10.3892/ijo.2018.4597. 10.3892/ijo.2018.4597

[27]

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21:183–203. https://doi.org/10.1038/s41580-019-0199-y. 10.1038/s41580-019-0199-y

[28]

Aksamitiene E, Kiyatkin A, Kholodenko BN. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans. 2012;40:139–46. https://doi.org/10.1042/BST20110609. 10.1042/bst20110609

[29]

Liang B, Liang JM, Ding JN, Xu J, Xu JG, Chai YM. Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway. Stem Cell Res Ther. 2019;10:335. https://doi.org/10.1186/s13287-019-1410-y. 10.1186/s13287-019-1410-y

[30]

Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis

Lu Liu, Yaqin Liu, Chun Feng et al.

Biomaterials 2019 10.1016/j.biomaterials.2018.11.007

[31]

Hu H, Zhang H, Bu Z, Liu Z, Lv F, Pan M, Huang X, Cheng L. Small extracellular vesicles released from Bioglass/Hydrogel Scaffold promote vascularized bone regeneration by transferring miR-23a-3p. Int J Nanomed. 2022;17:6201–20. https://doi.org/10.2147/IJN.S389471. 10.2147/ijn.s389471

[32]

Wu J, Kuang L, Chen C, Yang J, Zeng WN, Li T, Chen H, Huang S, Fu Z, Li J, et al. Mir-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206:87–100. https://doi.org/10.1016/j.biomaterials.2019.03.022. 10.1016/j.biomaterials.2019.03.022

[33]

Shen K, Duan A, Cheng J, Yuan T, Zhou J, Song H, Chen Z, Wan B, Liu J, Zhang X, et al. Exosomes derived from hypoxia preconditioned mesenchymal stem cells laden in a silk hydrogel promote cartilage regeneration via the miR-205-5p/PTEN/AKT pathway. Acta Biomater. 2022;143:173–88. https://doi.org/10.1016/j.actbio.2022.02.026. 10.1016/j.actbio.2022.02.026

[34]

Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, Zhao C, Li H, Li YM, Zhao J. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med. 2018;22:261–76. https://doi.org/10.1111/jcmm.13316. 10.1111/jcmm.13316

[35]

Luo L, Gong J, Wang Z, Liu Y, Cao J, Qin J, Zuo R, Zhang H, Wang S, Zhao P, et al. Injectable cartilage matrix hydrogel loaded with cartilage endplate stem cells engineered to release exosomes for non-invasive treatment of intervertebral disc degeneration. Bioact Mater. 2022;15:29–43. https://doi.org/10.1016/j.bioactmat.2021.12.007. 10.1016/j.bioactmat.2021.12.007

[36]

Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, Jiang D, Gong F, Li L, Chen J, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation. 2020;17. https://doi.org/10.1186/s12974-020-1726-7. 10.1186/s12974-020-1726-7

[37]

Chen J, Zhang C, Li S, Li Z, Lai X, Xia Q. Exosomes Derived from Nerve Stem Cells Loaded with FTY720 Promote the Recovery after Spinal Cord Injury in Rats by PTEN/AKT Signal Pathway. J Immunol Res 2021, 2021, 8100298, https://doi.org/10.1155/2021/8100298. 10.1155/2021/8100298

[38]

Cao Y, Xu Y, Chen C, Xie H, Lu H, Hu J. Local delivery of USC-derived exosomes harboring ANGPTL3 enhances spinal cord functional recovery after injury by promoting angiogenesis. Stem Cell Res Ther. 2021;12:20. https://doi.org/10.1186/s13287-020-02078-8. 10.1186/s13287-020-02078-8

[39]

Fan L, Liu C, Chen X, Zheng L, Zou Y, Wen H, Guan P, Lu F, Luo Y, Tan G, et al. Exosomes-Loaded Electroconductive Hydrogel synergistically promotes tissue repair after spinal cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2022;9:e2105586. https://doi.org/10.1002/advs.202105586. 10.1002/advs.202105586

[40]

Yoon EJ, Choi Y, Kim TM, Choi EK, Kim YB, Park D. The neuroprotective effects of Exosomes Derived from TSG101-Overexpressing human neural stem cells in a stroke model. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23179532. 10.3390/ijms23179532

[41]

Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound Healing: a Cellular Perspective. Physiol Rev. 2019;99:665–706. https://doi.org/10.1152/physrev.00067.2017. 10.1152/physrev.00067.2017

[42]

Ding J, Wang X, Chen B, Zhang J, Xu J. Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Stimulated by Deferoxamine Accelerate Cutaneous Wound Healing by Promoting Angiogenesis. Biomed Res Int 2019, 2019, 9742765, https://doi.org/10.1155/2019/9742765. 10.1155/2019/9742765

[43]

Zhang W, Bai X, Zhao B, Li Y, Zhang Y, Li Z, Wang X, Luo L, Han F, Zhang J, et al. Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway. Exp Cell Res. 2018;370:333–42. https://doi.org/10.1016/j.yexcr.2018.06.035. 10.1016/j.yexcr.2018.06.035

[44]

Geng X, Qi Y, Liu X, Shi Y, Li H, Zhao L. A multifunctional antibacterial and self-healing hydrogel laden with bone marrow mesenchymal stem cell-derived exosomes for accelerating diabetic wound healing. Biomater Adv. 2022;133:112613. https://doi.org/10.1016/j.msec.2021.112613. 10.1016/j.msec.2021.112613

[45]

Jiang T, Liu S, Wu Z, Li Q, Ren S, Chen J, Xu X, Wang C, Lu C, Yang X, Chen Z. ADSC-exo@MMP-PEG smart hydrogel promotes diabetic wound healing by optimizing cellular functions and relieving oxidative stress. Mater Today Bio. 2022;16. https://doi.org/10.1016/j.mtbio.2022.100365. 10.1016/j.mtbio.2022.100365

[46]

Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y, Kang Y. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis. Drug Deliv. 2022;29:440–53. https://doi.org/10.1080/10717544.2022.2030428. 10.1080/10717544.2022.2030428

[47]

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva, David Brenner

Nature Reviews Gastroenterology & Hepatology 2021 10.1038/s41575-020-00372-7

[48]

Wen Z, Mai Z, Zhu X, Wu T, Chen Y, Geng D, Wang J. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11:36. https://doi.org/10.1186/s13287-020-1563-8. 10.1186/s13287-020-1563-8

[49]

Chen J, Huang T, Liu R, Wang C, Jiang H, Sun H. Congenital microtia patients: the genetically engineered exosomes released from porous gelatin methacryloyl hydrogel for downstream small RNA profiling, functional modulation of microtia chondrocytes and tissue-engineered ear cartilage regeneration. J Nanobiotechnol. 2022;20:164. https://doi.org/10.1186/s12951-022-01352-6. 10.1186/s12951-022-01352-6

[50]

30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology

Qian Zhang, Michael J. Lenardo, David Baltimore

Cell 2017 10.1016/j.cell.2016.12.012

Showing 50 of 182 references

Cited By

30

Adipose stem cell-derived exosomes as emerging neurotherapeutics in obesity induced diabetic neuropathy

Dilip Kumar Arya, Luce Perie · 2026

Biomedicine & Pharmacotherapy

Metrics

30

Citations

182

References

Details

Published: Aug 20, 2024
Vol/Issue: 14(1)
License: View

Authors

Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China

Funding

National Natural Science Foundation of China Award: 82271192

Cite This Article

Ding Li, Danni Li, Jiaojiao Li, et al. (2024). Signaling pathways activated and regulated by stem cell-derived exosome therapy. Cell & Bioscience, 14(1). https://doi.org/10.1186/s13578-024-01277-7

Signaling pathways activated and regulated by stem cell-derived exosome therapy

You May Also Like